SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 66.79   -6.13 (-8.41%) Volume: 745.86k 4:00 PM EDT 27-Mar-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities108/17/2018
4Statement of changes in beneficial ownership of securities108/17/2018
8-KCurrent report pursuant to Section 13 or 15(d)708/09/2018
10-QGeneral form for quarterly reports under Section 13 or 15(d)9808/08/2018
4Statement of changes in beneficial ownership of securities108/07/2018
8-KCurrent report pursuant to Section 13 or 15(d)1308/06/2018
8-KCurrent report pursuant to Section 13 or 15(d)707/30/2018
8-KCurrent report pursuant to Section 13 or 15(d)307/11/2018
4/A[Amend] Statement of changes in beneficial ownership of securities107/03/2018
4Statement of changes in beneficial ownership of securities107/03/2018
4Statement of changes in beneficial ownership of securities107/03/2018
4Statement of changes in beneficial ownership of securities107/03/2018
4/A[Amend] Statement of changes in beneficial ownership of securities107/03/2018
4/A[Amend] Statement of changes in beneficial ownership of securities107/03/2018
4/A[Amend] Statement of changes in beneficial ownership of securities107/03/2018
34567891011121314151617